Evaluation of Jaundice in Adults.
Fargo MV, Grogan SP, Saguil A.
Am Fam Physician. 2017 Feb 1;95(3):164-168.
Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.
Chen HL, Wu SH, Hsu SH, Liou BY, Chen HL, Chang MH.
J Biomed Sci. 2018 Oct 26;25(1):75. doi: 10.1186/s12929-018-0475-8.
Hepatocellular carcinoma presenting with obstructive jaundice.
Lai EC, Lau WY.
ANZ J Surg. 2006 Jul;76(7):631-6. doi: 10.1111/j.1445-2197.2006.03794.x.
Hepatocellular carcinoma with obstructive jaundice: endoscopic and percutaneous biliary drainage.
Minami Y, Kudo M.
Dig Dis. 2012;30(6):592-7. doi: 10.1159/000343087. Epub 2012 Dec 13.
Gene replacement therapy for genetic hepatocellular jaundice.
van Dijk R, Beuers U, Bosma PJ.
Clin Rev Allergy Immunol. 2015 Jun;48(2-3):243-53. doi: 10.1007/s12016-014-8454-7.
Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.
Qin LX, Tang ZY.
World J Gastroenterol. 2003 Mar;9(3):385-91. doi: 10.3748/wjg.v9.i3.385.
Efficacy of (125)I Versus Non-(125)I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice.
Li S, He X, Dang L, Xu F, Fang J, Li F, Wang W.
Dig Dis Sci. 2018 Feb;63(2):321-328. doi: 10.1007/s10620-017-4899-x. Epub 2018 Jan 5.
Fibrolamellar hepatocellular carcinoma presenting as cholestatic jaundice: An unusual presentation of a rare disease.
Singh A, Goyal S, Mehta V, Kakkar C, Narang V, Sood A.
Indian J Pathol Microbiol. 2023 Apr-Jun;66(2):385-387. doi: 10.4103/ijpm.ijpm_316_21.
A rare cause of obstructive jaundice in a patient with hepatocellular carcinoma.
Ryou SY, Sung PS.
Dig Liver Dis. 2022 Dec;54(12):1721-1722. doi: 10.1016/j.dld.2022.08.015. Epub 2022 Aug 20.
Jaundice 8years after left hemi-hepatectomy for hepatocellular carcinoma.
Yang SS, Wu X, Lu J, Cheng NS.
Clin Res Hepatol Gastroenterol. 2020 Oct;44(5):622-624. doi: 10.1016/j.clinre.2019.11.009. Epub 2019 Dec 26.
